CD4 and neoplasm: Treating mice with RA190 reduces Arginase and iNOS expression in MDSCs, increases the number of CD8+ cytotoxic lymphocytes, and reduces the number of CD4+CD25+FoxP3+ Tregs in the tumor microenvironment